#264 What's Wrong With Having Lots of Patents? Patent Thickets and Antitrust Law
It's often said that patent protection rewards innovation and benefits consumers. But are there competition law issues with having "too many" patents? Kate Swisher, an antitrust litigator at White & C...
11 Mars 202428min
#263 What's the Role of a Magistrate Judge? Conversation With Judge Lindsey Vaala
The U.S. federal district courts have magistrate judges who are appointed to assist the district court judges and generally oversee first appearances of criminal defendants, set bail, and conduct othe...
4 Mars 202433min
#262 What's Up With U.S. Merger Remedies?
The US antitrust agencies' approach to merger remedies has undergone a significant change under the Biden administration. Remedies are increasingly disfavored. In this episode, Dan Ducore, former Assi...
26 Feb 202428min
#261 Can Demanding Price Parity Harm Competition? The MFN Paradox
When are MFNs good and when are they bad? A "most favored nation" (MFN) price requirement ensures that a buyer receives the lowest price that a seller is offering to other buyers. Under U.S. antitrust...
19 Feb 202422min
#260 What's The (Data Protection) Difference? An EU/U.S. Comparison of Personal Data Protection Issues In Merger and Behavioural Investigations
Large amounts of information are collected during merger control and behavioural competition law investigations. What are the personal data protection issues raised? Dan Rupprecht, Director for Europe...
12 Feb 202436min
#259 Is Competition in Canada in Decline?
In recent years competition agencies in several jurisdictions have undertaken studies to assess the state of competition within their borders. Canada now joins the list. In this episode, co-hosts Alic...
5 Feb 202424min
#258 Will the UK CMA Find Out About My Deal? The Operation of the CMA's Mergers Intelligence Committee in Practice
The UK merger control system provides for voluntary filings but that does not mean parties to deals can hide from the regulator, the UK Competition and Markets Authority (CMA). But how does the CMA's ...
29 Jan 202432min
#257 Throwing the Book at Orange Book Listings? The FTC's Views on the Antitrust Implications of Listing Patents in the Orange Book
The interplay between patent law and competition law has been a consistent focus for the antitrust agencies over the years, most notably in the pharmaceutical sector between brand and generic drugs. B...
22 Jan 202430min
